The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tarlatamab in small cell lung cancer with brain metastases: A real-world experience.
 
Santiago Sucre
No Relationships to Disclose
 
Chinmay Jani
No Relationships to Disclose
 
Dan Morgenstern
No Relationships to Disclose
 
Nelsy Zuniga
No Relationships to Disclose
 
Rakhi Modak
No Relationships to Disclose
 
Kyle Edwards
No Relationships to Disclose
 
Brandon Rose
No Relationships to Disclose
 
Subul Malik
No Relationships to Disclose
 
Kyle Rowley
No Relationships to Disclose
 
Asad Rauf
No Relationships to Disclose
 
Gilberto Lopes
Stock and Other Ownership Interests - Biomab; CDR-Life; Immorta Bio; Lucence Diagnostics; Morphometrix; Xilis
Honoraria - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Dr. Reddy's Laboratories; Janssen; Merck; Rigel
Consulting or Advisory Role - AstraZeneca; Coherus Biosciences; Dr. Reddy's Laboratories; Mirati Therapeutics; Pfizer; Regeneron
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); E.R. Squibb Sons, LLC; EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst); Xilis
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; Boehringer Ingelheim; Celgene; Coherus Biosciences; Dr. Reddy's Laboratories; E.R. Squibb Sons, LLC; Ipsen; Janssen; Merck; Pfizer; Pharmacyclics; Seagen; Seagen
 
Estelamari Rodriguez
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; E.R. Squibb Sons, LLC; Janssen Oncology; Natera; Nuvalent, Inc.; NuvationBio; Pfizer; Turning Point Therapeutics
 
Aman Chauhan
Stock and Other Ownership Interests - Elicio Therapeutics; immatics; Kura Oncology; MIST; Revolution Medicines
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Boehringer Ingelheim; Crinetics Pharmaceuticals; Curium Pharma; Exelixis; Sanofi/Aventis
Research Funding - Merck KGaA (Inst); NanoPharmaceuticals (Inst); Seneca Therapeutics (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions